PRESCRIBING FOR OLDER ADULTS AND PREGNANT WOMEN
2. Choose one of the two following specific populations below and select specific disorder from the DSM-5 to use.
1. Pregnant women
2. Older adults
3. Based on your selection for either pregnant women or older adults:
4. Recommend one FDA-approved drug (use a credible scholarly resource to support)
5. Recommend one off-label drug (use a credible scholarly resource to support)
6. Recommend one nonpharmacological intervention for treating (use a credible scholarly resource to support)
4. Based on your selection for either pregnant women or older adults:
5. Explain the risk assessment you would use to inform your treatment decision-making.
6. Explain the risks and benefits of the FDA-approved medicine
7. Explain the risks and benefits of the off-label drug
5. Based on your selection for either pregnant women or older adults:
6. Explain whether clinical practice guidelines exist for this disorder
7. If clinical practice guidelines exist for the diagnosis, use them to justify your recommendations.
8. If clinical practice guidelines does not exist for the diagnosis, explain what information you would need to take into consideration.
9. Support your reasoning with at least three current, credible scholarly resources from the 2016-2021. I will accept 2015-2021 will be acceptable as well.
6. Respondto at least two of your colleagues on 2 different days who selected different disorders. a. Propose an alternative on-label
7. Propose an alternative off-label pharmacological treatment
8. Propose an alternative nonpharmacological treatment for the disorders
9. Justify your suggestions with at least two references to the literature
****REMEMBER TO SUPPORT YOUR FINDINGS WITH RESEARCH…EVIDENCE BASE PRACTICE**** You are unable to get the max points without research validation. However, some parts specifically request you to support your rationale with research. To receive max points in any of the areas would require critical thinking=research validation
· American Psychiatric Association. (2020). Geriatric telepsychiatryLinks to an external site. [Video]. https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/toolkit/geriatric-telepsychiatry
· American Psychiatric Association. (2016). The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementiaLinks to an external site. . https://doi.org/10.1176/appi.books.9780890426807
· Agency for Healthcare Research and Quality. (2019). Maternal and fetal effects of mental health treatments in pregnant and breastfeeding women: A systematic review of pharmacological interventionsLinks to an external site. . https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
· Hardy, L. T., & Reichenbacker, O. L. (2019). A practical guide to the use of psychotropic medications during pregnancy and lactationLinks to an external site. . Archives of Psychiatric Nursing, 33(3), 254–266. https://doi.org/10.1016/j.apnu.2019.04.001
· National Library of Medicine. (2006–2020). Drugs and lactation databaseLinks to an external site. (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK501922/
· The LactMed® database is a peer-reviewed, evidence-based resource on drugs that may be used by breastfeeding mothers. It includes possible effects on nursing infants and offers drug alternatives where possible.
· Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer.
· Chapter 27, “Psychiatry and Reproductive Medicine”
· Chapter 33, “Geriatric Psychiatry”
· Stewart, J. G., & DeNisco, S. M. (2019). Role development for the nurse practitioner (2nd ed.) . Jones & Bartlett Learning.
· Chapter 3, “Vulnerable Populations”
· Chapter 4, “Mental Health and Primary Care: A Critical Intersection”
· Chapter 5, “Cultural Sensitivity and Global Health”